Science Advisory Board
Science Advisory Board
RudaCure's Science Advisory Board (SAB) comprises world-class experts in ion channel pharmacology, pain research, ophthalmology, and AI-driven drug discovery, providing strategic guidance for our core pipeline.

Dr. Yong-ho Kim
SAB Chair / CEO
Professor, Gachon University College of Medicine
Over 15 years of basic medical research in pain and sensory disorders. Founder of the TRPV1 ion channel modulation-based drug development platform.
Dr. Jiyoon Shin
Research Director
RudaCure Central Research Institute
Expert in AI-driven drug development efficiency. Leads core technology development of the RuCIA platform with structure-based molecular design.

Prof. Donghyun Kim
EVP / Clinical Advisor
Korea University Anam Hospital, Dept. of Ophthalmology
Demonstrated RCI001 long-term safety and Sjögren's syndrome efficacy. Recipient of KOES Academic Award and Taejun Best Ophthalmology Paper Award.

Prof. Dohun Kwon
External Advisor
POSTECH (Pohang University of Science and Technology)
Expert in TRPV1 ion channel structural analysis. Conducting joint research with RudaCure on TRPV1 structure-activity relationships.

Dr. Anat Galor, MD, MSPH
External Advisor
Bascom Palmer Eye Institute, University of Miami
Professor of Ophthalmology at Bascom Palmer Eye Institute. World-renowned authority on dry eye disease and neuropathic ocular pain. PI on multiple NIH grants, 355+ publications (h-index 51). Named to The Ophthalmologist Power List.

Dr. Victor L. Perez, MD
External Advisor
Bascom Palmer Eye Institute, University of Miami
Professor of Ophthalmology and Director of Cornea Research at Bascom Palmer Eye Institute. Led the TFOS DEWS III global dry eye consensus guidelines. Harvard Medical School trained, NIH/CDC research fellow. The Ophthalmologist Power List 2026.
Role of the SAB
Scientific validation and strategic guidance for pipeline programs
Clinical trial design and regulatory strategy advisory
Global academic network connectivity
New indication discovery and technology expansion advisory